142 related articles for article (PubMed ID: 20002699)
1. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
[TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Metser U; You J; McSweeney S; Freeman M; Hendler A
AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
[TBL] [Abstract][Full Text] [Related]
4. Serum carcinoembryonic antigen measurement, abdominal contrast-enhanced computed tomography, and fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of colorectal cancer recurrence: a correlative study.
Ozkan E; Soydal C; Araz M; Aras G
Nucl Med Commun; 2012 Sep; 33(9):990-4. PubMed ID: 22842225
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
6. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations.
Kyoto Y; Momose M; Kondo C; Itabashi M; Kameoka S; Kusakabe K
Ann Nucl Med; 2010 Jun; 24(5):395-401. PubMed ID: 20364373
[TBL] [Abstract][Full Text] [Related]
7. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level.
Lee JH; Park SG; Jee KN; Park DG; Namgung H; Song IH
Nucl Med Commun; 2010 Jun; 31(6):576-82. PubMed ID: 20216474
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
9. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs.
Kawamura YJ; Tokumitsu A; Mizokami K; Sasaki J; Tsujinaka S; Konishi F
Clin Colorectal Cancer; 2010 Jan; 9(1):48-51. PubMed ID: 20100688
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes in Asymptomatic Patients With Normal Conventional Imaging but Raised Carcinoembryonic Antigen Levels in Colorectal Cancer Following Positron Emission Tomography-Computed Tomography Imaging.
Khan K; Athauda A; Aitken K; Cunningham D; Watkins D; Starling N; Cook GJ; Kalaitzaki E; Chau I; Rao S
Oncologist; 2016 Dec; 21(12):1502-1508. PubMed ID: 27742904
[TBL] [Abstract][Full Text] [Related]
11. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
[TBL] [Abstract][Full Text] [Related]
12. Value of ¹⁸F-FDG PET-CT in surveillance of postoperative colorectal cancer patients with various carcinoembryonic antigen concentrations.
Zhang Y; Feng B; Zhang GL; Hu M; Fu Z; Zhao F; Zhang XL; Kong L; Yu JM
World J Gastroenterol; 2014 Jun; 20(21):6608-14. PubMed ID: 24914384
[TBL] [Abstract][Full Text] [Related]
13. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.
Kantorová I; Lipská L; Bêlohlávek O; Visokai V; Trubaĉ M; Schneiderová M
J Nucl Med; 2003 Nov; 44(11):1784-8. PubMed ID: 14602860
[TBL] [Abstract][Full Text] [Related]
14. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
15. Yield of routine imaging after curative colorectal cancer treatment.
Jochmans I; Topal B; D'Hoore A; Aerts R; Vanbeckevoort D; Bielen D; Haustermans K; Van Cutsem E; Penninckx F
Acta Chir Belg; 2008; 108(1):88-92. PubMed ID: 18411580
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence.
Makis W; Kurzencwyg D; Hickeson M
Clin Imaging; 2013; 37(6):1094-7. PubMed ID: 23993799
[TBL] [Abstract][Full Text] [Related]
17. PET/CT pattern analysis for surgical staple line recurrence in patients with colorectal cancer.
Shyn PB; Madan R; Wu C; Erturk SM; Silverman SG
AJR Am J Roentgenol; 2010 Feb; 194(2):414-21. PubMed ID: 20093604
[TBL] [Abstract][Full Text] [Related]
18. The role of FDG PET/CT in patients with colorectal cancer metastases.
Kochhar R; Liong S; Manoharan P
Cancer Biomark; 2010; 7(4):235-48. PubMed ID: 21576816
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level.
Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh B; Kapoor R; Gupta R
Nucl Med Commun; 2011 Sep; 32(9):789-93. PubMed ID: 21760561
[TBL] [Abstract][Full Text] [Related]
20. Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer.
Bleeker WA; Mulder NH; Hermans J; Otter R; Plukker JT
Br J Surg; 2001 Jan; 88(1):101-6. PubMed ID: 11136320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
